JTO Clinical and Research Reports Pulmonary and Respiratory Medicine
Results From a Multi-Center Survey Among Physicians and Patients on the Acceptance of New Treatment Strategy With Third Generation of EGFR-TKI Plus Bispecific Antibody for Advanced EGFR-Mutant NSCLC
The publisher did not provide an abstract — full text is available via the link below.